The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

I've finally got my hands on the latest mobile processor from AMD for this review of the ROG Flow Z13 (2025). It's impressive ...

TransAlta Corporation faces stock declines and challenges but focuses on renewables & strategic growth. Evaluate its ...

Tonner Drones Answers Questions From Shareholders Schiltigheim, February 21th 2025 8:00, Tonner Drones ('the Company') today publishes the answers to questions it has received from shareholders in the ...

SynAct Pharma AB (publ) ("SynAct") today announced its Year-end Report 2024. "SynAct Pharma was running at full speed during the fourth quarter. The team has done a fantastic job ensuring our Phase 2b ...

It has had its bright spots but the half-year reporting season turned ugly this week. To make matters worse, the Reserve Bank ...

Canadian mining company Ivanhoe Mines is entering a new phase of strong free cash flow generation, following the completion of peak capital expenditures at its flagship Kamoa-Kakula copper complex in ...